Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
AstraZeneca
Mayo Clinic
Mayo Clinic
Kivu Bioscience Inc.
MediLink Therapeutics (Suzhou) Co., Ltd.
Convalife (Shanghai) Co., Ltd.
Neonc Technologies, Inc.
ViroMissile, Inc.
Arcus Biosciences, Inc.
Bristol-Myers Squibb
Sichuan Enray Pharmaceutical Sciences Company
AstraZeneca
AstraZeneca
Tizona Therapeutics, Inc
Eli Lilly and Company
University of Colorado, Denver
MacroGenics
Karolinska University Hospital
SystImmune Inc.
Pheon Therapeutics
Daiichi Sankyo
Eli Lilly and Company
Adela, Inc
Orano Med LLC
Radiopharm Theranostics, Ltd
ImmunityBio, Inc.
Eli Lilly and Company
Ocellaris Pharma, Inc.
Medical College of Wisconsin
Innate Pharma
Mayo Clinic
Tanabe Pharma America, Inc.
Radiopharm Theranostics, Ltd
HiFiBiO Therapeutics
DualityBio Inc.
TScan Therapeutics, Inc.
University of Pittsburgh
Rondo Therapeutics
Incyte Corporation
Actym Therapeutics, Inc.
M.D. Anderson Cancer Center
University of Arizona
Chongqing Precision Biotech Co., Ltd
LigaChem Biosciences, Inc.
Merck Sharp & Dohme LLC
Washington University School of Medicine
Institut Claudius Regaud
Travera Inc